Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA554221
Max Phase: Preclinical
Molecular Formula: C24H37ClN2
Molecular Weight: 352.57
Molecule Type: Small molecule
Associated Items:
ID: ALA554221
Max Phase: Preclinical
Molecular Formula: C24H37ClN2
Molecular Weight: 352.57
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCCCCCCCCCCN=c1ccn(Cc2ccccc2)cc1.Cl
Standard InChI: InChI=1S/C24H36N2.ClH/c1-2-3-4-5-6-7-8-9-10-14-19-25-24-17-20-26(21-18-24)22-23-15-12-11-13-16-23;/h11-13,15-18,20-21H,2-10,14,19,22H2,1H3;1H
Standard InChI Key: SZZFGCLYDYICBT-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 352.57 | Molecular Weight (Monoisotopic): 352.2878 | AlogP: 6.36 | #Rotatable Bonds: 13 |
Polar Surface Area: 17.29 | Molecular Species: BASE | HBA: 2 | HBD: 0 |
#RO5 Violations: 1 | HBA (Lipinski): 2 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: 10.40 | CX LogP: 7.50 | CX LogD: 4.64 |
Aromatic Rings: 2 | Heavy Atoms: 26 | QED Weighted: 0.37 | Np Likeness Score: -0.36 |
1. Wentland MP, Bailey DM, Powles RG, Slee AM, Sedlock DM.. (1988) The in vitro dental plaque inhibitory properties of a series of N-[1-alkyl-4(1H)-pyridinylidene]alkylamines., 31 (10): [PMID:3172139] [10.1021/jm00118a030] |
Source(1):